Sign Up for Vincent AI
Teva Pharms. USA, Inc. v. Mylan Pharms. Inc.
OPINION TEXT STARTS HERE
David M. Hashmall, Goodwin Procter, LLP, Elizabeth J. Holland, Miriam London Martinez, Steven Jeffrey Lee, Carolyn Anne Blessing, Patrice Polyxene Jean, Kenyon & Kenyon, Jeffrey A. Simes, Jonathan Aaron Auerbach, Joseph B. Crystal, Goodwin Procter, LLP, Brian Jeffrey Eutermoser, Weil, Gotshal & Manges LLP, New York, NY, Daryl L. Wiesen, John T. Bennett, Nicholas K. Mitrokostas, Goodwin Procter, LLP, Boston, MA, William G. James, II, Kenyon & Kenyon LLP, Washington, DC, for Plaintiffs.
Anders T. Aannestad, Brian Matthew Kramer, David C. Doyle, Morrison & Foerster LLP, San Diego, CA, Karen Louise Hagberg, Richard B. Mills-Robertson, Morrison & Foerster LLP, Andrew Levine, Friedman, Kaplan, Seiler & Adelman LLP, Beth D. Jacob, Schiff Hardin LLP, New York, NY, David L. Anstaett, Sarah C. Walkenhorst, Perkins Coie LLP, Madison, WI, Ricardo Solano, Jr., Friedman, Kaplan, Seiler & Adelman LLP, Newark, NJ, for Defendants.
Opinion and Order
5 cases
Janssen Prods., L.P. v. Lupin Ltd.
"...is "an inextricable and essential part of what doctors are prescribing" when they prescribe Prezista. Teva Pharms. USA, Inc. v. Sandoz, Inc., 876 F.Supp.2d 295, 416–17 (S.D.N.Y.2012), aff'd, 723 F.3d 1363 (Fed.Cir.2013), cert. granted on other issues, ––– U.S. ––––, 134 S.Ct. 1761, 188 L.Ed..."
AstraZeneca LP v. Breath Ltd.
"...and effective drug often supports the nonobviousness of a drug that finally achieves success.” Teva Pharma. USA, Inc. v. Sandoz, Inc., 876 F.Supp.2d 295, 417 (S.D.N.Y.2012). AstraZeneca introduced evidence of its own failures to create the claimed budesonide compositions using conventional ..."
Depomed, Inc. v. Actavis Elizabeth LLC
"...the patents may be demonstrated by an ANDA filer's certification and Notice Letter to the patent holder. Teva Pham. U.S.A., Inc. v. Sandoz, Inc., 876 F. Supp. 2d 295, 349 (S.D.N.Y 2012). In assessing whether an asserted noninfringing use is substantial, the factfinder considers not only the..."
Chin–McKenzie v. Continuum Health Partners
"... ... Inc. (“Continuum”) and Long Island College ... See Amnesty Int'l USA v. Clapper, 638 F.3d 118, 129 n. 13 (2d ... "
Bristol-Myers Squibb Co. v. Teva Pharm. USA, Inc.
"...Inc., 935 F.2d 1569, 1578 (Fed.Cir.1991) (internal quotation marks and citation omitted); see also Teva Pharm. USA, Inc. v. Sandoz, Inc., 876 F.Supp.2d 295, 417 (S.D.N.Y.2012) (“The repeated failure of others to solve a problem addressed by an invention is further confirmation of the invent..."
Try vLex and Vincent AI for free
Start a free trial2 books and journal articles
Use of Reissue Proceedings in Hatch-Waxman Litigation
"...found, again, that the ’808 patent was indefinite. On November 5, 2015, Teva then asked the Supreme 51. Teva Pharms. USA, Inc. v. Sandoz, Inc., 876 F. Supp. 2d 295 (S.D.N.Y. 2012), aff’d in part, rev’d in part, 723 F.3d 1363 (Fed. Cir. 2013), judgment vacated, 135 S. Ct. 831. Of the nine pa..."
Use of Reissue Proceedings in Hatch-Waxman Litigation
"...that the ’808 patent was indefinite. On November 5, 2015, Teva then asked the Supreme 51. Teva Pharms. USA, Inc. v. Sandoz, Inc., 876 F. Supp. 2d 295 (S.D.N.Y. 2012), aff’d in part, rev’d in part, 723 F.3d 1363 (Fed. Cir. 2013), judgment vacated, 135 S. Ct. 831. Of the nine patents, seven w..."
Try vLex and Vincent AI for free
Start a free trial1 firm's commentaries
Supreme Court To Consider Federal Circuit De Novo Review Of Claim Construction In Teva Pharmaceuticals USA Inc. V. Sandoz Inc.
"...that a person of ordinary skill in the art would know to use the peak average molecular weight. Teva Pharm. USA, Inc. v. Sandoz, Inc., 876 F. Supp. 2d 295, 400 -01 (S.D.N.Y. 2012) aff'd in part, rev'd in part, 723 F.3d 1363 (Fed. Cir. 2013) cert. granted, 13-854, 2014 WL 199529 (U.S. Mar. 3..."
Try vLex and Vincent AI for free
Start a free trialExperience vLex's unparalleled legal AI
Access millions of documents and let Vincent AI power your research, drafting, and document analysis — all in one platform.
Start Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting
2 books and journal articles
Use of Reissue Proceedings in Hatch-Waxman Litigation
"...found, again, that the ’808 patent was indefinite. On November 5, 2015, Teva then asked the Supreme 51. Teva Pharms. USA, Inc. v. Sandoz, Inc., 876 F. Supp. 2d 295 (S.D.N.Y. 2012), aff’d in part, rev’d in part, 723 F.3d 1363 (Fed. Cir. 2013), judgment vacated, 135 S. Ct. 831. Of the nine pa..."
Use of Reissue Proceedings in Hatch-Waxman Litigation
"...that the ’808 patent was indefinite. On November 5, 2015, Teva then asked the Supreme 51. Teva Pharms. USA, Inc. v. Sandoz, Inc., 876 F. Supp. 2d 295 (S.D.N.Y. 2012), aff’d in part, rev’d in part, 723 F.3d 1363 (Fed. Cir. 2013), judgment vacated, 135 S. Ct. 831. Of the nine patents, seven w..."
Try vLex and Vincent AI for free
Start a free trialStart Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting
5 cases
Janssen Prods., L.P. v. Lupin Ltd.
"...is "an inextricable and essential part of what doctors are prescribing" when they prescribe Prezista. Teva Pharms. USA, Inc. v. Sandoz, Inc., 876 F.Supp.2d 295, 416–17 (S.D.N.Y.2012), aff'd, 723 F.3d 1363 (Fed.Cir.2013), cert. granted on other issues, ––– U.S. ––––, 134 S.Ct. 1761, 188 L.Ed..."
AstraZeneca LP v. Breath Ltd.
"...and effective drug often supports the nonobviousness of a drug that finally achieves success.” Teva Pharma. USA, Inc. v. Sandoz, Inc., 876 F.Supp.2d 295, 417 (S.D.N.Y.2012). AstraZeneca introduced evidence of its own failures to create the claimed budesonide compositions using conventional ..."
Depomed, Inc. v. Actavis Elizabeth LLC
"...the patents may be demonstrated by an ANDA filer's certification and Notice Letter to the patent holder. Teva Pham. U.S.A., Inc. v. Sandoz, Inc., 876 F. Supp. 2d 295, 349 (S.D.N.Y 2012). In assessing whether an asserted noninfringing use is substantial, the factfinder considers not only the..."
Chin–McKenzie v. Continuum Health Partners
"... ... Inc. (“Continuum”) and Long Island College ... See Amnesty Int'l USA v. Clapper, 638 F.3d 118, 129 n. 13 (2d ... "
Bristol-Myers Squibb Co. v. Teva Pharm. USA, Inc.
"...Inc., 935 F.2d 1569, 1578 (Fed.Cir.1991) (internal quotation marks and citation omitted); see also Teva Pharm. USA, Inc. v. Sandoz, Inc., 876 F.Supp.2d 295, 417 (S.D.N.Y.2012) (“The repeated failure of others to solve a problem addressed by an invention is further confirmation of the invent..."
Try vLex and Vincent AI for free
Start a free trialStart Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting
Start Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting
1 firm's commentaries
Supreme Court To Consider Federal Circuit De Novo Review Of Claim Construction In Teva Pharmaceuticals USA Inc. V. Sandoz Inc.
"...that a person of ordinary skill in the art would know to use the peak average molecular weight. Teva Pharm. USA, Inc. v. Sandoz, Inc., 876 F. Supp. 2d 295, 400 -01 (S.D.N.Y. 2012) aff'd in part, rev'd in part, 723 F.3d 1363 (Fed. Cir. 2013) cert. granted, 13-854, 2014 WL 199529 (U.S. Mar. 3..."